SlideShare a Scribd company logo
Adherence to Treatment
Adherencia al Tratamiento
Antje-Henriette Fink-Wagner, PhD
Executive Director
Global Allergy and Asthma Patient Platform GAAPP
Antje-Henriette Fink-Wagner, 2012 1
Statement of Interest
No conflict of interest!
Antje-Henriette Fink-Wagner, 2012 2
– Status of Health Literacy as relevant issue to be adherent/
concordant
– Patient advocacy as 1st step to empower patients and to
increase adherence/concordance for better patient compliance
– Integral meaning and consequences of compliance
– Model of patient behavior
– Integration of all stakeholders to change patient behavior
– Conclusion
Examples: – Physician
– Nurse
– Pharmacist
– Insurance/funds
– Family and friends
– Policy Makers
– Pharmaceutical industry
– Patient associations
Content
or what you will take home from this presentation
Antje-Henriette Fink-Wagner, 2012 3
– Literacy and misunderstanding prescription drug labels.
Annals of Internal Medicine 2006 :
Take two tablets twice daily.
How many patients can follow this direction?
Health Literacy
a precondition to achieve acceptable adherence/concordance
Antje-Henriette Fink-Wagner, 2012 4
– Literacy and misunderstanding prescription drug labels.
Annals of Internal Medicine 2006 :
Take two tablets twice daily.
How many patients can follow this direction?
Only 34 % of patients were able to accurately follow this!
Health Literacy
a precondition to achieve acceptable adherence/concordance
Antje-Henriette Fink-Wagner, 2012 5
Patient advocacy as 1st step to empower patients and
to increase adherence/concordance for better patient
compliance
– Advocacy empowers patients
– Empowered patients are more willing to feel responsible
for their therapy
– Patients who feel responsible want to understand
therapy opportunities, which means they request
education
– Educated patients are able to adhere to doctors‘ advice on
a level of concordance
– Concordance
will increase compliance
Patient advocacy will increase compliance
Antje-Henriette Fink-Wagner, 2012 6
Source:
Reality of non-compliance
Compliance is the main challenge for optimal treatment of
patients in general
Antje-Henriette Fink-Wagner, 2012 7
Source: N. Barber, J. Parsons, S. Clifford, R. Darracott, R. Horne; Qual Saf Health Care
2004; 13: 172-175, doi: 10.1136/ qshc.2003.005926
Still taking medication at 10 days
(n = 226/239)
Still taking medication at 4 weeks
(n = 171/197)
Adherent
Non-adherent
Partial non-adherence
Complete non-adherence
159 (70%)
67 (30%)
49
18
128 (75%)
43 (25%)
26
17
Adherence to new medication:
Patients‘ problems with new medication
for chronic conditions
Antje-Henriette Fink-Wagner, 2012 8
Source: F.A. Al-Eidan et al. J Clin Pharmacol 2002, 53, 163-171
Example
Compliance with and without help taking
medication in Hp eradication therapy
Antje-Henriette Fink-Wagner, 2012 9
Valerie uses her spray
twice daily –
without any relief!
… without any problems?
Antje-Henriette Fink-Wagner, 2012 10
Model of patient behavior
Levendahl, et al. stated 1992:
Patients personal ideas
about their illness are often
organized around five
components:
– Identity
– Timeline
– Cause
– Consequences
– Control/cure
These can be thought of
as the answers to five basic
questions about the illness
or health threat:
– What is it?
– How long will it last?
– What causes it?
– How will it/has it affected me?
– Can it be controlled or cured?
People form a mental model or representation of the illness,
which is made up of their answers to these questions.
Antje-Henriette Fink-Wagner, 2012 11
Conclusion
How can patient behavior be changed
Physician
Antje-Henriette Fink-Wagner, 2012 12
Physician
Motivational interviewing: Ask open questions in
Patient friendly language
What changes would you most like to talk about?
What have you noticed about…….?
How important is it for you to change…?
How confident do you feel about changing…?
How do you see the benefits
Source:
Physician
Antje-Henriette Fink-Wagner, 2012 13
BMJ 2010
Physician
Physician
Motivational interviewing
Develop Discrepancy
– How does current behavior
conflict with core values?
Minimize Unsolicited Advice
– Patients overcomes their own obstracles
– Dance not a wrestling match
Support Self-Efficacy
– Uncover and reinforce it
Usual Suspects
– Express empathy
– Good nonverbal listening skills
– Be a problem solving partners Antje-Henriette Fink-Wagner, 2012 14
Physician
Physician
Never forget the WRITTEN action plan!
Red Zone: Stop! Danger!
Yellow Zone: Caution! Slow Down!
Green Zone: Go!
Antje-Henriette Fink-Wagner, 2012 15
Conclusion
How can patient behavior be changed
Nurse
Antje-Henriette Fink-Wagner, 2012 16
NurseExample: Nurse
Phone Dialog
doctor – patient – nurse triangle
COPD case management
by National Jewish Medical
and Research Center
– Individualized by patient and physician
– Driven by action plans from physician
– Nurses handle calls based on
developed algorithms as kind of call center
– Inbound and outbound calls
through Case Manager (nurse)
– Physicians always notified
– Can be done every 12 or 24 hours and will be
less after few weeks
Antje-Henriette Fink-Wagner, 2012 17
National Jewish Medical and Research Center
COPD all plan members
12-month utilization data
0 Adult Days Missed
from Work
n = 272
500
1500
ER Visits
n = 751
Hospitalizations
n = 751
Unscheduled Dr. Visits
n = 751
Oral Antibiotic Bursts
n = 746
1383
245
164
582
Baseline
7 to 12 Months
p < 0.001
1000
756
-79.7%
281
-70.7%
48
- 48.2%
127
-58.9%
239
-45.1%
415
Source: Data provided by David Tinkelman, vice president Health Initiatives NJC, December 2002
NurseExample: Nurse
Antje-Henriette Fink-Wagner, 2012 18
Conclusion
How can patient behavior be changed
Pharmacist
Antje-Henriette Fink-Wagner, 2012 19
PharmacistExample: Pharmacist
EFA Allergy Awareness Project 2011-2014:
Pharmacists are the first Health Care Professionals
seeing a patient on risk for allergies when asking for
OTC products.
Situation: People often “know” they have an allergy but
do not go for proper diagnosis.
Aim: Use pharmacists to motivate potential allergy
patients to visit a doctor for proper diagnosis and
therapy.
Pilot project planed in Austria and Germany to proof
positive role of pharmacists in 2013.
Antje-Henriette Fink-Wagner, 2012 20
Pharmacist
Voilà – Amuse gueule!
Appetizer …
Antje-Henriette Fink-Wagner, 2012 21
Conclusion
How can patient behavior be changed
Insurance/
Funds
Antje-Henriette Fink-Wagner, 2012 22
Source: Techniker Krankenkasse, 2005; www.tk-online.de
Example: Insurance/Funds
Reminder service
Reminder service for preventive measures
of members
– Dental prophylaxis
– Health check-up
– Cancer prophylaxis
– Preventive care for children and youths
– Smoking cessation
Telephone reminder or information by e-mail
as requested by the member
Insurance/
Funds
Antje-Henriette Fink-Wagner, 2012 23
Source: Techniker Krankenkasse, www.tk-online.de, Januar 2005
Example: Insurance/Funds
Diagnostic information for members
– After online entry of a diagnosis (often provided in codes only),
a diagnosis text is displayed in patient friendly language
– including additional information, e.g. links to treatment guidelines
Insurance/
Funds
Antje-Henriette Fink-Wagner, 2012 24
Source: Chest 2011
Insurance/Funds
The impact of co pay costs on non adherence Insurance/
Funds
Antje-Henriette Fink-Wagner, 2012 25
Rates of cost-related non-adherence (black bars) by monthly out-of-pocket
inhaler costs in the Inhaler +/CPD+ group. There is a roughly linear increases in
cost –related non-adherence as the out-of-pocket costs of inhalers increases
(test for trend, P<.0001). Error bars represent SEM.
Conclusion
How can patient behavior be changed
Family
and
Friends
Antje-Henriette Fink-Wagner, 2012 26
Example: Family and Friends
Smoking cessation
“Feel free to say no”,
an initiative of the European Union:
Testimonials presents the friends
of the target groups
Antje-Henriette Fink-Wagner, 2012 27
Paul, hurry!
You have to be at
the doctor’s
at eleven …
Memory function …
Family
and
Friends
Antje-Henriette Fink-Wagner, 2012 28
Conclusion
How can patient behavior be changed
Public/
Policy Makers
Antje-Henriette Fink-Wagner, 2012 29
Policy Makers
Health Literacy: a precondition to achieve acceptable
adherence/concordance
Public
Policy Makers
Antje-Henriette Fink-Wagner, 2012 30
European Health Award October 2012 :
• Survey of the HLS-EU CONSORTIUM
Source: HLS-EU CONSORTIUM (2012): COMPARATIVE REPORT OF HEALTH LITERACY IN EIGHT EU MEMBER STATES. THE EUROPEAN HEALTH LITERACY SURVEY HLS-EU , ONLINE PUBLICATION:
HTTP://WWW.HEALTH-LITERACY.EU
About 12% of
respondents
have inadequate general
health literacy, and more
than one third (35%)
problematic health
literacy, thus nearly
every second respondent
shows limited health
literacy,
in the general sample.
8000 respondents from
8 countries.
Joint messages in as many countries
As possible
Public
World Awareness days
Public
Policy Makers
Creates awareness about a special
disease to patients, public and Policy Makers
Antje-Henriette Fink-Wagner, 2012 31
Conclusion
How can patient behavior be changed
Pharma-
ceutical
Industry
Antje-Henriette Fink-Wagner, 2012 32
Pharma-
ceutical
Industry
Example: Pharmaceutical Industry
ZacPac
History
3 packages to eradicate Hp:
PPI plus two different antibiotics
(French triple therapy)
Compliance friendly solution
Development of ONE compliance-supporting
medication package for all three drugs
– Received the international award
Antje-Henriette Fink-Wagner, 2012 33
Example: Technical Industry
Helping Hand™
– Electronic tool offered
by Bang & Olufsen
– Reminds patients to take
medication correctly
– Helps patients to feel secure on
level of compliance
– In use for 4 indications
(CNS, cardiovascular,
osteoporosis, immune suppression)
– Improves compliance from
45 – 80% and 95% of doctors
believe patients benefit from it
– Increased persistence
affects market shares
(according to B&O)
Pharma-
ceutical
Industry
Antje-Henriette Fink-Wagner, 2012 34
Conclusion
How can patient behavior be changed
Patient
Associations
Antje-Henriette Fink-Wagner, 2012 35
Patient Association
European Federation of Allergy and Airways
Diseases Patient Associations EFA
– 32 Member organizations in 22 countries
– EFA Respiratory Allergy Awareness Project:
– Raise awareness of respiratory allergies (Rhinoconjunctivitis and
Allergic Asthma Rhinitis, Asthma) as serious chronic disease
– Call for
– Early identification of symptoms by target audience
– Early diagnosis and appropriate strategies including life style changes
and physical activities to manage and control allergic diseases to
– Avoid exacerbations of severe allergies
Patient
Associations
Antje-Henriette Fink-Wagner, 2012 36
EFA Call to Action
– EU policy-makers are called to coordinate actions to
1) Increase the political recognition of respiratory allergies as a
real and serious disease
2) Promote national programmes on respiratory allergies
3) Prioritize the management and control of respiratory allergies
4) Promote training in allergy for healthcare professionals to
improve accurate and early diagnosis
5) Align healthcare and reimbursement policies, to support
appropriate disease management
6) Improve indoor air quality
Invitation to sign the EFA Call to Action:
http://www.efacallaction.net/sign.aspx Antje-Henriette Fink-Wagner, 2012
Patient
Associations
Patient Association
Global Allergy and Asthma Patient Platform
– 24 member organizations on all
Continents
– Sport Games for children with asthma to promote
adherence to sport for asthmatics (see first talk of this
session)
Antje-Henriette Fink-Wagner, 2012 38
Conclusion
Adherence / Concordance will improve
as the sum of individual advocacy initiatives
by all allied healthcare professionals and the
patients themselves.
Antje-Henriette Fink-Wagner, 2012 39
COMPLY –
OR DIE
Thank You!
Antje-Henriette Fink-Wagner, 2012 40

More Related Content

What's hot

Patient engagement in medication safety at the point of care – roles, respons...
Patient engagement in medication safety at the point of care – roles, respons...Patient engagement in medication safety at the point of care – roles, respons...
Patient engagement in medication safety at the point of care – roles, respons...
Canadian Patient Safety Institute
 
Walking in Patients' Shoes: My Home Blood Pressure Monitoring Experience
Walking in Patients' Shoes: My Home Blood Pressure Monitoring ExperienceWalking in Patients' Shoes: My Home Blood Pressure Monitoring Experience
Walking in Patients' Shoes: My Home Blood Pressure Monitoring Experience
Ted Eytan, MD, MS, MPH
 
DayOne Accelerator 2019/20 shortlisted projects
DayOne Accelerator 2019/20 shortlisted projectsDayOne Accelerator 2019/20 shortlisted projects
DayOne Accelerator 2019/20 shortlisted projects
DayOne
 
Consumer Health Information
Consumer Health InformationConsumer Health Information
Consumer Health Information
Robin Featherstone
 
​You’re kidding, right? Patients to help with antimicrobial resistance?
​You’re kidding, right? Patients to help with antimicrobial resistance?​You’re kidding, right? Patients to help with antimicrobial resistance?
​You’re kidding, right? Patients to help with antimicrobial resistance?
Canadian Patient Safety Institute
 
How to Reduce Readmissions by Changing Patient Education
How to Reduce Readmissions by Changing Patient EducationHow to Reduce Readmissions by Changing Patient Education
How to Reduce Readmissions by Changing Patient Education
Chuck Jones
 
20 tendencias digitales en salud digital_ The Medical Futurist
20 tendencias digitales en salud digital_ The Medical Futurist20 tendencias digitales en salud digital_ The Medical Futurist
20 tendencias digitales en salud digital_ The Medical Futurist
Richard Canabate
 
Understanding Trust in OTC Medicines Survey Research
Understanding Trust in OTC Medicines Survey ResearchUnderstanding Trust in OTC Medicines Survey Research
Understanding Trust in OTC Medicines Survey Research
Your Health at Hand
 
mHealth solutions method for the coordinated health care
mHealth solutions method for the coordinated health caremHealth solutions method for the coordinated health care
mHealth solutions method for the coordinated health care
3GDR
 
kBot: Knowledge-Enabled Personalized Chatbot for Self-Management of Asthma in...
kBot: Knowledge-Enabled Personalized Chatbot for Self-Management of Asthma in...kBot: Knowledge-Enabled Personalized Chatbot for Self-Management of Asthma in...
kBot: Knowledge-Enabled Personalized Chatbot for Self-Management of Asthma in...
Artificial Intelligence Institute at UofSC
 
Innovation in Care Delivery: The Patient Journey
Innovation in Care Delivery: The Patient JourneyInnovation in Care Delivery: The Patient Journey
Innovation in Care Delivery: The Patient JourneyJane Chiang
 
AUC Specialty Choice Webinar | All About Pediatrics
AUC Specialty Choice Webinar | All About PediatricsAUC Specialty Choice Webinar | All About Pediatrics
AUC Specialty Choice Webinar | All About Pediatrics
American University of the Caribbean School of Medicine
 
Allergycosteffectivenessslides r4132004
Allergycosteffectivenessslides r4132004Allergycosteffectivenessslides r4132004
Allergycosteffectivenessslides r4132004Carlos Alberto Trapani
 
Consumer health
Consumer healthConsumer health
Consumer health
Cey Gloria
 
Eysenbach: Consumer health informatics
Eysenbach: Consumer health informaticsEysenbach: Consumer health informatics
Eysenbach: Consumer health informatics
Gunther Eysenbach
 
Stanford UniversityDiabetes Health Literacy Project 030614
Stanford UniversityDiabetes Health Literacy Project 030614Stanford UniversityDiabetes Health Literacy Project 030614
Stanford UniversityDiabetes Health Literacy Project 030614David Donohue
 
Web only rx16 treat-wed_1115_1_hudson_2bada
Web only rx16 treat-wed_1115_1_hudson_2badaWeb only rx16 treat-wed_1115_1_hudson_2bada
Web only rx16 treat-wed_1115_1_hudson_2bada
OPUNITE
 

What's hot (18)

Patient engagement in medication safety at the point of care – roles, respons...
Patient engagement in medication safety at the point of care – roles, respons...Patient engagement in medication safety at the point of care – roles, respons...
Patient engagement in medication safety at the point of care – roles, respons...
 
Walking in Patients' Shoes: My Home Blood Pressure Monitoring Experience
Walking in Patients' Shoes: My Home Blood Pressure Monitoring ExperienceWalking in Patients' Shoes: My Home Blood Pressure Monitoring Experience
Walking in Patients' Shoes: My Home Blood Pressure Monitoring Experience
 
DayOne Accelerator 2019/20 shortlisted projects
DayOne Accelerator 2019/20 shortlisted projectsDayOne Accelerator 2019/20 shortlisted projects
DayOne Accelerator 2019/20 shortlisted projects
 
Consumer Health Information
Consumer Health InformationConsumer Health Information
Consumer Health Information
 
​You’re kidding, right? Patients to help with antimicrobial resistance?
​You’re kidding, right? Patients to help with antimicrobial resistance?​You’re kidding, right? Patients to help with antimicrobial resistance?
​You’re kidding, right? Patients to help with antimicrobial resistance?
 
How to Reduce Readmissions by Changing Patient Education
How to Reduce Readmissions by Changing Patient EducationHow to Reduce Readmissions by Changing Patient Education
How to Reduce Readmissions by Changing Patient Education
 
Clarity
ClarityClarity
Clarity
 
20 tendencias digitales en salud digital_ The Medical Futurist
20 tendencias digitales en salud digital_ The Medical Futurist20 tendencias digitales en salud digital_ The Medical Futurist
20 tendencias digitales en salud digital_ The Medical Futurist
 
Understanding Trust in OTC Medicines Survey Research
Understanding Trust in OTC Medicines Survey ResearchUnderstanding Trust in OTC Medicines Survey Research
Understanding Trust in OTC Medicines Survey Research
 
mHealth solutions method for the coordinated health care
mHealth solutions method for the coordinated health caremHealth solutions method for the coordinated health care
mHealth solutions method for the coordinated health care
 
kBot: Knowledge-Enabled Personalized Chatbot for Self-Management of Asthma in...
kBot: Knowledge-Enabled Personalized Chatbot for Self-Management of Asthma in...kBot: Knowledge-Enabled Personalized Chatbot for Self-Management of Asthma in...
kBot: Knowledge-Enabled Personalized Chatbot for Self-Management of Asthma in...
 
Innovation in Care Delivery: The Patient Journey
Innovation in Care Delivery: The Patient JourneyInnovation in Care Delivery: The Patient Journey
Innovation in Care Delivery: The Patient Journey
 
AUC Specialty Choice Webinar | All About Pediatrics
AUC Specialty Choice Webinar | All About PediatricsAUC Specialty Choice Webinar | All About Pediatrics
AUC Specialty Choice Webinar | All About Pediatrics
 
Allergycosteffectivenessslides r4132004
Allergycosteffectivenessslides r4132004Allergycosteffectivenessslides r4132004
Allergycosteffectivenessslides r4132004
 
Consumer health
Consumer healthConsumer health
Consumer health
 
Eysenbach: Consumer health informatics
Eysenbach: Consumer health informaticsEysenbach: Consumer health informatics
Eysenbach: Consumer health informatics
 
Stanford UniversityDiabetes Health Literacy Project 030614
Stanford UniversityDiabetes Health Literacy Project 030614Stanford UniversityDiabetes Health Literacy Project 030614
Stanford UniversityDiabetes Health Literacy Project 030614
 
Web only rx16 treat-wed_1115_1_hudson_2bada
Web only rx16 treat-wed_1115_1_hudson_2badaWeb only rx16 treat-wed_1115_1_hudson_2bada
Web only rx16 treat-wed_1115_1_hudson_2bada
 

Similar to Adherencia al Tratamiento. Dr. Antjefink Wagner

BM THESIS HTA LIT BM THESIS De Kinderen et al (2013)
BM THESIS HTA LIT BM THESIS De Kinderen et al (2013)BM THESIS HTA LIT BM THESIS De Kinderen et al (2013)
BM THESIS HTA LIT BM THESIS De Kinderen et al (2013)Roel Rinkens
 
ITU Presentation: mHealth - The Doctor's Side
ITU Presentation: mHealth - The Doctor's SideITU Presentation: mHealth - The Doctor's Side
ITU Presentation: mHealth - The Doctor's Side
Jeannine Lemaire
 
Neil Dugdale sobi crdn summit 2017
Neil Dugdale sobi crdn summit 2017Neil Dugdale sobi crdn summit 2017
Neil Dugdale sobi crdn summit 2017
CamRARE Disease Network
 
digital health lecture slide v6
digital health lecture slide v6digital health lecture slide v6
digital health lecture slide v6Brian Lee
 
Trigger Point – Self-medication: Patients in white coats
Trigger Point – Self-medication: Patients in white coats Trigger Point – Self-medication: Patients in white coats
Trigger Point – Self-medication: Patients in white coats
inemet
 
Bringing Researchers, Families/ Patients, and Providers Together to Improve A...
Bringing Researchers, Families/ Patients, and Providers Together to Improve A...Bringing Researchers, Families/ Patients, and Providers Together to Improve A...
Bringing Researchers, Families/ Patients, and Providers Together to Improve A...
Utah's Annual Health Services Research Conference
 
WhereArePatientsinDecisionMaking
WhereArePatientsinDecisionMakingWhereArePatientsinDecisionMaking
WhereArePatientsinDecisionMakingPhilippa Göranson
 
WhereArePatientsinDecisionMaking
WhereArePatientsinDecisionMakingWhereArePatientsinDecisionMaking
WhereArePatientsinDecisionMakingSuzanne Parsons
 
Tom Deblanco: maximising patient engagement
Tom Deblanco: maximising patient engagementTom Deblanco: maximising patient engagement
Tom Deblanco: maximising patient engagement
Nuffield Trust
 
Partnering with Patients: Designing, Participating in and Reporting Health Ou...
Partnering with Patients: Designing, Participating in and Reporting Health Ou...Partnering with Patients: Designing, Participating in and Reporting Health Ou...
Partnering with Patients: Designing, Participating in and Reporting Health Ou...
patvocates
 
The benefits of patient involvement in research and development (RE:ACT Congr...
The benefits of patient involvement in research and development (RE:ACT Congr...The benefits of patient involvement in research and development (RE:ACT Congr...
The benefits of patient involvement in research and development (RE:ACT Congr...
jangeissler
 
What can we learn from developing medicines information for patients?
What can we learn from developing medicines information for patients?What can we learn from developing medicines information for patients?
What can we learn from developing medicines information for patients?
HLGUK
 
Debating the Future of Spontaneous Reporting - Dr. Andrew Rut, CEO and Founde...
Debating the Future of Spontaneous Reporting - Dr. Andrew Rut, CEO and Founde...Debating the Future of Spontaneous Reporting - Dr. Andrew Rut, CEO and Founde...
Debating the Future of Spontaneous Reporting - Dr. Andrew Rut, CEO and Founde...
MyMeds&Me
 
Patient Advocates in Cancer Research: European Patients’ Perspective - Jan ...
Patient Advocates in Cancer Research: European Patients’ Perspective - Jan ...Patient Advocates in Cancer Research: European Patients’ Perspective - Jan ...
Patient Advocates in Cancer Research: European Patients’ Perspective - Jan ...
patvocates
 
Patient View - The need for user-defined guidelines for health apps
Patient View - The need for user-defined guidelines for health appsPatient View - The need for user-defined guidelines for health apps
Patient View - The need for user-defined guidelines for health apps
In The Pocket
 
The Role Of Telehealth In Emerging Models Of Care
The Role Of Telehealth In Emerging Models Of CareThe Role Of Telehealth In Emerging Models Of Care
The Role Of Telehealth In Emerging Models Of Care
Yasnof
 
Safety Improvement in Primary Care
Safety Improvement in Primary CareSafety Improvement in Primary Care
Safety Improvement in Primary Care
NHSScotlandEvent
 
· For this assignment you will use the Quantitative and the Qualit
· For this assignment you will use the Quantitative and the Qualit· For this assignment you will use the Quantitative and the Qualit
· For this assignment you will use the Quantitative and the Qualit
LesleyWhitesidefv
 
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI
 

Similar to Adherencia al Tratamiento. Dr. Antjefink Wagner (20)

BM THESIS HTA LIT BM THESIS De Kinderen et al (2013)
BM THESIS HTA LIT BM THESIS De Kinderen et al (2013)BM THESIS HTA LIT BM THESIS De Kinderen et al (2013)
BM THESIS HTA LIT BM THESIS De Kinderen et al (2013)
 
ITU Presentation: mHealth - The Doctor's Side
ITU Presentation: mHealth - The Doctor's SideITU Presentation: mHealth - The Doctor's Side
ITU Presentation: mHealth - The Doctor's Side
 
Neil Dugdale sobi crdn summit 2017
Neil Dugdale sobi crdn summit 2017Neil Dugdale sobi crdn summit 2017
Neil Dugdale sobi crdn summit 2017
 
digital health lecture slide v6
digital health lecture slide v6digital health lecture slide v6
digital health lecture slide v6
 
Trigger Point – Self-medication: Patients in white coats
Trigger Point – Self-medication: Patients in white coats Trigger Point – Self-medication: Patients in white coats
Trigger Point – Self-medication: Patients in white coats
 
Bringing Researchers, Families/ Patients, and Providers Together to Improve A...
Bringing Researchers, Families/ Patients, and Providers Together to Improve A...Bringing Researchers, Families/ Patients, and Providers Together to Improve A...
Bringing Researchers, Families/ Patients, and Providers Together to Improve A...
 
WhereArePatientsinDecisionMaking
WhereArePatientsinDecisionMakingWhereArePatientsinDecisionMaking
WhereArePatientsinDecisionMaking
 
WhereArePatientsinDecisionMaking
WhereArePatientsinDecisionMakingWhereArePatientsinDecisionMaking
WhereArePatientsinDecisionMaking
 
Tom Deblanco: maximising patient engagement
Tom Deblanco: maximising patient engagementTom Deblanco: maximising patient engagement
Tom Deblanco: maximising patient engagement
 
Partnering with Patients: Designing, Participating in and Reporting Health Ou...
Partnering with Patients: Designing, Participating in and Reporting Health Ou...Partnering with Patients: Designing, Participating in and Reporting Health Ou...
Partnering with Patients: Designing, Participating in and Reporting Health Ou...
 
The benefits of patient involvement in research and development (RE:ACT Congr...
The benefits of patient involvement in research and development (RE:ACT Congr...The benefits of patient involvement in research and development (RE:ACT Congr...
The benefits of patient involvement in research and development (RE:ACT Congr...
 
What can we learn from developing medicines information for patients?
What can we learn from developing medicines information for patients?What can we learn from developing medicines information for patients?
What can we learn from developing medicines information for patients?
 
Debating the Future of Spontaneous Reporting - Dr. Andrew Rut, CEO and Founde...
Debating the Future of Spontaneous Reporting - Dr. Andrew Rut, CEO and Founde...Debating the Future of Spontaneous Reporting - Dr. Andrew Rut, CEO and Founde...
Debating the Future of Spontaneous Reporting - Dr. Andrew Rut, CEO and Founde...
 
Patient involvement
Patient involvementPatient involvement
Patient involvement
 
Patient Advocates in Cancer Research: European Patients’ Perspective - Jan ...
Patient Advocates in Cancer Research: European Patients’ Perspective - Jan ...Patient Advocates in Cancer Research: European Patients’ Perspective - Jan ...
Patient Advocates in Cancer Research: European Patients’ Perspective - Jan ...
 
Patient View - The need for user-defined guidelines for health apps
Patient View - The need for user-defined guidelines for health appsPatient View - The need for user-defined guidelines for health apps
Patient View - The need for user-defined guidelines for health apps
 
The Role Of Telehealth In Emerging Models Of Care
The Role Of Telehealth In Emerging Models Of CareThe Role Of Telehealth In Emerging Models Of Care
The Role Of Telehealth In Emerging Models Of Care
 
Safety Improvement in Primary Care
Safety Improvement in Primary CareSafety Improvement in Primary Care
Safety Improvement in Primary Care
 
· For this assignment you will use the Quantitative and the Qualit
· For this assignment you will use the Quantitative and the Qualit· For this assignment you will use the Quantitative and the Qualit
· For this assignment you will use the Quantitative and the Qualit
 
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
EUPATI 2013 Conference: Vision on Patient involvement in medicines R&D: Here...
 

More from Sociedad Latinoamericana de Alergia, Asma e Inmunología

Sesión Académica del CRAIC "El eje de la psiconeuroinmunoendocrinología y las...
Sesión Académica del CRAIC "El eje de la psiconeuroinmunoendocrinología y las...Sesión Académica del CRAIC "El eje de la psiconeuroinmunoendocrinología y las...
Sesión Académica del CRAIC "El eje de la psiconeuroinmunoendocrinología y las...
Sociedad Latinoamericana de Alergia, Asma e Inmunología
 
Sesión Clínica de Alergia del CRAIC "Asma en el embarazo"
Sesión Clínica de Alergia del CRAIC "Asma en el embarazo"Sesión Clínica de Alergia del CRAIC "Asma en el embarazo"
Sesión Clínica de Alergia del CRAIC "Asma en el embarazo"
Sociedad Latinoamericana de Alergia, Asma e Inmunología
 
Sesión Académica del CRAIC "Hipersensibilidad a medios de contraste"
Sesión Académica del CRAIC "Hipersensibilidad a medios de contraste"Sesión Académica del CRAIC "Hipersensibilidad a medios de contraste"
Sesión Académica del CRAIC "Hipersensibilidad a medios de contraste"
Sociedad Latinoamericana de Alergia, Asma e Inmunología
 
Sesión Clínica de Alergia del CRAIC "Hipersensibilidad a quinolonas"
Sesión Clínica de Alergia del CRAIC "Hipersensibilidad a quinolonas"Sesión Clínica de Alergia del CRAIC "Hipersensibilidad a quinolonas"
Sesión Clínica de Alergia del CRAIC "Hipersensibilidad a quinolonas"
Sociedad Latinoamericana de Alergia, Asma e Inmunología
 
Sesión Académica del CRAIC "Hipersensibilidad a Beta lactámicos"
Sesión Académica del CRAIC "Hipersensibilidad a Beta lactámicos"Sesión Académica del CRAIC "Hipersensibilidad a Beta lactámicos"
Sesión Académica del CRAIC "Hipersensibilidad a Beta lactámicos"
Sociedad Latinoamericana de Alergia, Asma e Inmunología
 
Sesión Académica del CRAIC "Hipersensibilidad a anticonvulsivantes"
Sesión Académica del CRAIC "Hipersensibilidad a anticonvulsivantes"Sesión Académica del CRAIC "Hipersensibilidad a anticonvulsivantes"
Sesión Académica del CRAIC "Hipersensibilidad a anticonvulsivantes"
Sociedad Latinoamericana de Alergia, Asma e Inmunología
 
Sesión de Aerobiología del CRAIC "Ácaro, perro, gato y cucaracha"
Sesión de Aerobiología del CRAIC "Ácaro, perro, gato y cucaracha"Sesión de Aerobiología del CRAIC "Ácaro, perro, gato y cucaracha"
Sesión de Aerobiología del CRAIC "Ácaro, perro, gato y cucaracha"
Sociedad Latinoamericana de Alergia, Asma e Inmunología
 
Sesión Académica del CRAIC "Reacciones de hipersensibilidad a AINEs"
Sesión Académica del CRAIC "Reacciones de hipersensibilidad a AINEs"Sesión Académica del CRAIC "Reacciones de hipersensibilidad a AINEs"
Sesión Académica del CRAIC "Reacciones de hipersensibilidad a AINEs"
Sociedad Latinoamericana de Alergia, Asma e Inmunología
 
Manifestaciones alérgicas de errores innatos de la inmunidad
Manifestaciones alérgicas de errores innatos de la inmunidadManifestaciones alérgicas de errores innatos de la inmunidad
Manifestaciones alérgicas de errores innatos de la inmunidad
Sociedad Latinoamericana de Alergia, Asma e Inmunología
 
Sesión Académica del CRAIC "Reacciones adversas cutáneas graves"
Sesión Académica del CRAIC "Reacciones adversas cutáneas  graves"Sesión Académica del CRAIC "Reacciones adversas cutáneas  graves"
Sesión Académica del CRAIC "Reacciones adversas cutáneas graves"
Sociedad Latinoamericana de Alergia, Asma e Inmunología
 
Sesión Académica del CRAIC "Hipersensibilidad a medicamentos"
Sesión Académica del CRAIC "Hipersensibilidad a medicamentos"Sesión Académica del CRAIC "Hipersensibilidad a medicamentos"
Sesión Académica del CRAIC "Hipersensibilidad a medicamentos"
Sociedad Latinoamericana de Alergia, Asma e Inmunología
 
Sesión Académica del CRAIC "Alergia a tatuajes, prótesis e implantes"
Sesión Académica del CRAIC "Alergia a tatuajes, prótesis e implantes"Sesión Académica del CRAIC "Alergia a tatuajes, prótesis e implantes"
Sesión Académica del CRAIC "Alergia a tatuajes, prótesis e implantes"
Sociedad Latinoamericana de Alergia, Asma e Inmunología
 
Sesión de Aerobiología del CRAIC "Aerobiología II: Árboles"
Sesión de Aerobiología del CRAIC "Aerobiología II: Árboles"Sesión de Aerobiología del CRAIC "Aerobiología II: Árboles"
Sesión de Aerobiología del CRAIC "Aerobiología II: Árboles"
Sociedad Latinoamericana de Alergia, Asma e Inmunología
 
Sesión Académica del CRAIC "Vasculitis".
Sesión Académica del CRAIC "Vasculitis".Sesión Académica del CRAIC "Vasculitis".
Sesión Académica del CRAIC "Vasculitis".
Sociedad Latinoamericana de Alergia, Asma e Inmunología
 
Sesión de Aerobiología del CRAIC "Aeropalinología: Pólenes I (Pastos)"
Sesión de Aerobiología del CRAIC "Aeropalinología: Pólenes I (Pastos)"Sesión de Aerobiología del CRAIC "Aeropalinología: Pólenes I (Pastos)"
Sesión de Aerobiología del CRAIC "Aeropalinología: Pólenes I (Pastos)"
Sociedad Latinoamericana de Alergia, Asma e Inmunología
 
Sesión Académica del CRAIC "¿Qué, cuándo y cómo introducir alimentos alergéni...
Sesión Académica del CRAIC "¿Qué, cuándo y cómo introducir alimentos alergéni...Sesión Académica del CRAIC "¿Qué, cuándo y cómo introducir alimentos alergéni...
Sesión Académica del CRAIC "¿Qué, cuándo y cómo introducir alimentos alergéni...
Sociedad Latinoamericana de Alergia, Asma e Inmunología
 
Sesión Académica del CRAIC "Esclerodermia localizada y Dermatomiositis juvenil"
Sesión Académica del CRAIC "Esclerodermia localizada y Dermatomiositis juvenil"Sesión Académica del CRAIC "Esclerodermia localizada y Dermatomiositis juvenil"
Sesión Académica del CRAIC "Esclerodermia localizada y Dermatomiositis juvenil"
Sociedad Latinoamericana de Alergia, Asma e Inmunología
 
Sesión Académica del CRAIC "Alergia al látex".
Sesión Académica del CRAIC "Alergia al látex".Sesión Académica del CRAIC "Alergia al látex".
Sesión Académica del CRAIC "Alergia al látex".
Sociedad Latinoamericana de Alergia, Asma e Inmunología
 
Sesión de Aerobiología del CRAIC "Introducción a la aerobiología"
Sesión de Aerobiología del CRAIC "Introducción a la aerobiología"Sesión de Aerobiología del CRAIC "Introducción a la aerobiología"
Sesión de Aerobiología del CRAIC "Introducción a la aerobiología"
Sociedad Latinoamericana de Alergia, Asma e Inmunología
 
Sesión Académica del CRAIC "Reacción por aditivos, conservadores y colorantes"
Sesión Académica del CRAIC "Reacción por aditivos, conservadores y colorantes"Sesión Académica del CRAIC "Reacción por aditivos, conservadores y colorantes"
Sesión Académica del CRAIC "Reacción por aditivos, conservadores y colorantes"
Sociedad Latinoamericana de Alergia, Asma e Inmunología
 

More from Sociedad Latinoamericana de Alergia, Asma e Inmunología (20)

Sesión Académica del CRAIC "El eje de la psiconeuroinmunoendocrinología y las...
Sesión Académica del CRAIC "El eje de la psiconeuroinmunoendocrinología y las...Sesión Académica del CRAIC "El eje de la psiconeuroinmunoendocrinología y las...
Sesión Académica del CRAIC "El eje de la psiconeuroinmunoendocrinología y las...
 
Sesión Clínica de Alergia del CRAIC "Asma en el embarazo"
Sesión Clínica de Alergia del CRAIC "Asma en el embarazo"Sesión Clínica de Alergia del CRAIC "Asma en el embarazo"
Sesión Clínica de Alergia del CRAIC "Asma en el embarazo"
 
Sesión Académica del CRAIC "Hipersensibilidad a medios de contraste"
Sesión Académica del CRAIC "Hipersensibilidad a medios de contraste"Sesión Académica del CRAIC "Hipersensibilidad a medios de contraste"
Sesión Académica del CRAIC "Hipersensibilidad a medios de contraste"
 
Sesión Clínica de Alergia del CRAIC "Hipersensibilidad a quinolonas"
Sesión Clínica de Alergia del CRAIC "Hipersensibilidad a quinolonas"Sesión Clínica de Alergia del CRAIC "Hipersensibilidad a quinolonas"
Sesión Clínica de Alergia del CRAIC "Hipersensibilidad a quinolonas"
 
Sesión Académica del CRAIC "Hipersensibilidad a Beta lactámicos"
Sesión Académica del CRAIC "Hipersensibilidad a Beta lactámicos"Sesión Académica del CRAIC "Hipersensibilidad a Beta lactámicos"
Sesión Académica del CRAIC "Hipersensibilidad a Beta lactámicos"
 
Sesión Académica del CRAIC "Hipersensibilidad a anticonvulsivantes"
Sesión Académica del CRAIC "Hipersensibilidad a anticonvulsivantes"Sesión Académica del CRAIC "Hipersensibilidad a anticonvulsivantes"
Sesión Académica del CRAIC "Hipersensibilidad a anticonvulsivantes"
 
Sesión de Aerobiología del CRAIC "Ácaro, perro, gato y cucaracha"
Sesión de Aerobiología del CRAIC "Ácaro, perro, gato y cucaracha"Sesión de Aerobiología del CRAIC "Ácaro, perro, gato y cucaracha"
Sesión de Aerobiología del CRAIC "Ácaro, perro, gato y cucaracha"
 
Sesión Académica del CRAIC "Reacciones de hipersensibilidad a AINEs"
Sesión Académica del CRAIC "Reacciones de hipersensibilidad a AINEs"Sesión Académica del CRAIC "Reacciones de hipersensibilidad a AINEs"
Sesión Académica del CRAIC "Reacciones de hipersensibilidad a AINEs"
 
Manifestaciones alérgicas de errores innatos de la inmunidad
Manifestaciones alérgicas de errores innatos de la inmunidadManifestaciones alérgicas de errores innatos de la inmunidad
Manifestaciones alérgicas de errores innatos de la inmunidad
 
Sesión Académica del CRAIC "Reacciones adversas cutáneas graves"
Sesión Académica del CRAIC "Reacciones adversas cutáneas  graves"Sesión Académica del CRAIC "Reacciones adversas cutáneas  graves"
Sesión Académica del CRAIC "Reacciones adversas cutáneas graves"
 
Sesión Académica del CRAIC "Hipersensibilidad a medicamentos"
Sesión Académica del CRAIC "Hipersensibilidad a medicamentos"Sesión Académica del CRAIC "Hipersensibilidad a medicamentos"
Sesión Académica del CRAIC "Hipersensibilidad a medicamentos"
 
Sesión Académica del CRAIC "Alergia a tatuajes, prótesis e implantes"
Sesión Académica del CRAIC "Alergia a tatuajes, prótesis e implantes"Sesión Académica del CRAIC "Alergia a tatuajes, prótesis e implantes"
Sesión Académica del CRAIC "Alergia a tatuajes, prótesis e implantes"
 
Sesión de Aerobiología del CRAIC "Aerobiología II: Árboles"
Sesión de Aerobiología del CRAIC "Aerobiología II: Árboles"Sesión de Aerobiología del CRAIC "Aerobiología II: Árboles"
Sesión de Aerobiología del CRAIC "Aerobiología II: Árboles"
 
Sesión Académica del CRAIC "Vasculitis".
Sesión Académica del CRAIC "Vasculitis".Sesión Académica del CRAIC "Vasculitis".
Sesión Académica del CRAIC "Vasculitis".
 
Sesión de Aerobiología del CRAIC "Aeropalinología: Pólenes I (Pastos)"
Sesión de Aerobiología del CRAIC "Aeropalinología: Pólenes I (Pastos)"Sesión de Aerobiología del CRAIC "Aeropalinología: Pólenes I (Pastos)"
Sesión de Aerobiología del CRAIC "Aeropalinología: Pólenes I (Pastos)"
 
Sesión Académica del CRAIC "¿Qué, cuándo y cómo introducir alimentos alergéni...
Sesión Académica del CRAIC "¿Qué, cuándo y cómo introducir alimentos alergéni...Sesión Académica del CRAIC "¿Qué, cuándo y cómo introducir alimentos alergéni...
Sesión Académica del CRAIC "¿Qué, cuándo y cómo introducir alimentos alergéni...
 
Sesión Académica del CRAIC "Esclerodermia localizada y Dermatomiositis juvenil"
Sesión Académica del CRAIC "Esclerodermia localizada y Dermatomiositis juvenil"Sesión Académica del CRAIC "Esclerodermia localizada y Dermatomiositis juvenil"
Sesión Académica del CRAIC "Esclerodermia localizada y Dermatomiositis juvenil"
 
Sesión Académica del CRAIC "Alergia al látex".
Sesión Académica del CRAIC "Alergia al látex".Sesión Académica del CRAIC "Alergia al látex".
Sesión Académica del CRAIC "Alergia al látex".
 
Sesión de Aerobiología del CRAIC "Introducción a la aerobiología"
Sesión de Aerobiología del CRAIC "Introducción a la aerobiología"Sesión de Aerobiología del CRAIC "Introducción a la aerobiología"
Sesión de Aerobiología del CRAIC "Introducción a la aerobiología"
 
Sesión Académica del CRAIC "Reacción por aditivos, conservadores y colorantes"
Sesión Académica del CRAIC "Reacción por aditivos, conservadores y colorantes"Sesión Académica del CRAIC "Reacción por aditivos, conservadores y colorantes"
Sesión Académica del CRAIC "Reacción por aditivos, conservadores y colorantes"
 

Recently uploaded

How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
Rohit chaurpagar
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
DrSathishMS1
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
Catherine Liao
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 

Recently uploaded (20)

How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 

Adherencia al Tratamiento. Dr. Antjefink Wagner

  • 1. Adherence to Treatment Adherencia al Tratamiento Antje-Henriette Fink-Wagner, PhD Executive Director Global Allergy and Asthma Patient Platform GAAPP Antje-Henriette Fink-Wagner, 2012 1
  • 2. Statement of Interest No conflict of interest! Antje-Henriette Fink-Wagner, 2012 2
  • 3. – Status of Health Literacy as relevant issue to be adherent/ concordant – Patient advocacy as 1st step to empower patients and to increase adherence/concordance for better patient compliance – Integral meaning and consequences of compliance – Model of patient behavior – Integration of all stakeholders to change patient behavior – Conclusion Examples: – Physician – Nurse – Pharmacist – Insurance/funds – Family and friends – Policy Makers – Pharmaceutical industry – Patient associations Content or what you will take home from this presentation Antje-Henriette Fink-Wagner, 2012 3
  • 4. – Literacy and misunderstanding prescription drug labels. Annals of Internal Medicine 2006 : Take two tablets twice daily. How many patients can follow this direction? Health Literacy a precondition to achieve acceptable adherence/concordance Antje-Henriette Fink-Wagner, 2012 4
  • 5. – Literacy and misunderstanding prescription drug labels. Annals of Internal Medicine 2006 : Take two tablets twice daily. How many patients can follow this direction? Only 34 % of patients were able to accurately follow this! Health Literacy a precondition to achieve acceptable adherence/concordance Antje-Henriette Fink-Wagner, 2012 5
  • 6. Patient advocacy as 1st step to empower patients and to increase adherence/concordance for better patient compliance – Advocacy empowers patients – Empowered patients are more willing to feel responsible for their therapy – Patients who feel responsible want to understand therapy opportunities, which means they request education – Educated patients are able to adhere to doctors‘ advice on a level of concordance – Concordance will increase compliance Patient advocacy will increase compliance Antje-Henriette Fink-Wagner, 2012 6
  • 7. Source: Reality of non-compliance Compliance is the main challenge for optimal treatment of patients in general Antje-Henriette Fink-Wagner, 2012 7
  • 8. Source: N. Barber, J. Parsons, S. Clifford, R. Darracott, R. Horne; Qual Saf Health Care 2004; 13: 172-175, doi: 10.1136/ qshc.2003.005926 Still taking medication at 10 days (n = 226/239) Still taking medication at 4 weeks (n = 171/197) Adherent Non-adherent Partial non-adherence Complete non-adherence 159 (70%) 67 (30%) 49 18 128 (75%) 43 (25%) 26 17 Adherence to new medication: Patients‘ problems with new medication for chronic conditions Antje-Henriette Fink-Wagner, 2012 8
  • 9. Source: F.A. Al-Eidan et al. J Clin Pharmacol 2002, 53, 163-171 Example Compliance with and without help taking medication in Hp eradication therapy Antje-Henriette Fink-Wagner, 2012 9
  • 10. Valerie uses her spray twice daily – without any relief! … without any problems? Antje-Henriette Fink-Wagner, 2012 10
  • 11. Model of patient behavior Levendahl, et al. stated 1992: Patients personal ideas about their illness are often organized around five components: – Identity – Timeline – Cause – Consequences – Control/cure These can be thought of as the answers to five basic questions about the illness or health threat: – What is it? – How long will it last? – What causes it? – How will it/has it affected me? – Can it be controlled or cured? People form a mental model or representation of the illness, which is made up of their answers to these questions. Antje-Henriette Fink-Wagner, 2012 11
  • 12. Conclusion How can patient behavior be changed Physician Antje-Henriette Fink-Wagner, 2012 12
  • 13. Physician Motivational interviewing: Ask open questions in Patient friendly language What changes would you most like to talk about? What have you noticed about…….? How important is it for you to change…? How confident do you feel about changing…? How do you see the benefits Source: Physician Antje-Henriette Fink-Wagner, 2012 13 BMJ 2010
  • 14. Physician Physician Motivational interviewing Develop Discrepancy – How does current behavior conflict with core values? Minimize Unsolicited Advice – Patients overcomes their own obstracles – Dance not a wrestling match Support Self-Efficacy – Uncover and reinforce it Usual Suspects – Express empathy – Good nonverbal listening skills – Be a problem solving partners Antje-Henriette Fink-Wagner, 2012 14
  • 15. Physician Physician Never forget the WRITTEN action plan! Red Zone: Stop! Danger! Yellow Zone: Caution! Slow Down! Green Zone: Go! Antje-Henriette Fink-Wagner, 2012 15
  • 16. Conclusion How can patient behavior be changed Nurse Antje-Henriette Fink-Wagner, 2012 16
  • 17. NurseExample: Nurse Phone Dialog doctor – patient – nurse triangle COPD case management by National Jewish Medical and Research Center – Individualized by patient and physician – Driven by action plans from physician – Nurses handle calls based on developed algorithms as kind of call center – Inbound and outbound calls through Case Manager (nurse) – Physicians always notified – Can be done every 12 or 24 hours and will be less after few weeks Antje-Henriette Fink-Wagner, 2012 17
  • 18. National Jewish Medical and Research Center COPD all plan members 12-month utilization data 0 Adult Days Missed from Work n = 272 500 1500 ER Visits n = 751 Hospitalizations n = 751 Unscheduled Dr. Visits n = 751 Oral Antibiotic Bursts n = 746 1383 245 164 582 Baseline 7 to 12 Months p < 0.001 1000 756 -79.7% 281 -70.7% 48 - 48.2% 127 -58.9% 239 -45.1% 415 Source: Data provided by David Tinkelman, vice president Health Initiatives NJC, December 2002 NurseExample: Nurse Antje-Henriette Fink-Wagner, 2012 18
  • 19. Conclusion How can patient behavior be changed Pharmacist Antje-Henriette Fink-Wagner, 2012 19
  • 20. PharmacistExample: Pharmacist EFA Allergy Awareness Project 2011-2014: Pharmacists are the first Health Care Professionals seeing a patient on risk for allergies when asking for OTC products. Situation: People often “know” they have an allergy but do not go for proper diagnosis. Aim: Use pharmacists to motivate potential allergy patients to visit a doctor for proper diagnosis and therapy. Pilot project planed in Austria and Germany to proof positive role of pharmacists in 2013. Antje-Henriette Fink-Wagner, 2012 20
  • 21. Pharmacist Voilà – Amuse gueule! Appetizer … Antje-Henriette Fink-Wagner, 2012 21
  • 22. Conclusion How can patient behavior be changed Insurance/ Funds Antje-Henriette Fink-Wagner, 2012 22
  • 23. Source: Techniker Krankenkasse, 2005; www.tk-online.de Example: Insurance/Funds Reminder service Reminder service for preventive measures of members – Dental prophylaxis – Health check-up – Cancer prophylaxis – Preventive care for children and youths – Smoking cessation Telephone reminder or information by e-mail as requested by the member Insurance/ Funds Antje-Henriette Fink-Wagner, 2012 23
  • 24. Source: Techniker Krankenkasse, www.tk-online.de, Januar 2005 Example: Insurance/Funds Diagnostic information for members – After online entry of a diagnosis (often provided in codes only), a diagnosis text is displayed in patient friendly language – including additional information, e.g. links to treatment guidelines Insurance/ Funds Antje-Henriette Fink-Wagner, 2012 24
  • 25. Source: Chest 2011 Insurance/Funds The impact of co pay costs on non adherence Insurance/ Funds Antje-Henriette Fink-Wagner, 2012 25 Rates of cost-related non-adherence (black bars) by monthly out-of-pocket inhaler costs in the Inhaler +/CPD+ group. There is a roughly linear increases in cost –related non-adherence as the out-of-pocket costs of inhalers increases (test for trend, P<.0001). Error bars represent SEM.
  • 26. Conclusion How can patient behavior be changed Family and Friends Antje-Henriette Fink-Wagner, 2012 26
  • 27. Example: Family and Friends Smoking cessation “Feel free to say no”, an initiative of the European Union: Testimonials presents the friends of the target groups Antje-Henriette Fink-Wagner, 2012 27
  • 28. Paul, hurry! You have to be at the doctor’s at eleven … Memory function … Family and Friends Antje-Henriette Fink-Wagner, 2012 28
  • 29. Conclusion How can patient behavior be changed Public/ Policy Makers Antje-Henriette Fink-Wagner, 2012 29
  • 30. Policy Makers Health Literacy: a precondition to achieve acceptable adherence/concordance Public Policy Makers Antje-Henriette Fink-Wagner, 2012 30 European Health Award October 2012 : • Survey of the HLS-EU CONSORTIUM Source: HLS-EU CONSORTIUM (2012): COMPARATIVE REPORT OF HEALTH LITERACY IN EIGHT EU MEMBER STATES. THE EUROPEAN HEALTH LITERACY SURVEY HLS-EU , ONLINE PUBLICATION: HTTP://WWW.HEALTH-LITERACY.EU About 12% of respondents have inadequate general health literacy, and more than one third (35%) problematic health literacy, thus nearly every second respondent shows limited health literacy, in the general sample. 8000 respondents from 8 countries.
  • 31. Joint messages in as many countries As possible Public World Awareness days Public Policy Makers Creates awareness about a special disease to patients, public and Policy Makers Antje-Henriette Fink-Wagner, 2012 31
  • 32. Conclusion How can patient behavior be changed Pharma- ceutical Industry Antje-Henriette Fink-Wagner, 2012 32
  • 33. Pharma- ceutical Industry Example: Pharmaceutical Industry ZacPac History 3 packages to eradicate Hp: PPI plus two different antibiotics (French triple therapy) Compliance friendly solution Development of ONE compliance-supporting medication package for all three drugs – Received the international award Antje-Henriette Fink-Wagner, 2012 33
  • 34. Example: Technical Industry Helping Hand™ – Electronic tool offered by Bang & Olufsen – Reminds patients to take medication correctly – Helps patients to feel secure on level of compliance – In use for 4 indications (CNS, cardiovascular, osteoporosis, immune suppression) – Improves compliance from 45 – 80% and 95% of doctors believe patients benefit from it – Increased persistence affects market shares (according to B&O) Pharma- ceutical Industry Antje-Henriette Fink-Wagner, 2012 34
  • 35. Conclusion How can patient behavior be changed Patient Associations Antje-Henriette Fink-Wagner, 2012 35
  • 36. Patient Association European Federation of Allergy and Airways Diseases Patient Associations EFA – 32 Member organizations in 22 countries – EFA Respiratory Allergy Awareness Project: – Raise awareness of respiratory allergies (Rhinoconjunctivitis and Allergic Asthma Rhinitis, Asthma) as serious chronic disease – Call for – Early identification of symptoms by target audience – Early diagnosis and appropriate strategies including life style changes and physical activities to manage and control allergic diseases to – Avoid exacerbations of severe allergies Patient Associations Antje-Henriette Fink-Wagner, 2012 36
  • 37. EFA Call to Action – EU policy-makers are called to coordinate actions to 1) Increase the political recognition of respiratory allergies as a real and serious disease 2) Promote national programmes on respiratory allergies 3) Prioritize the management and control of respiratory allergies 4) Promote training in allergy for healthcare professionals to improve accurate and early diagnosis 5) Align healthcare and reimbursement policies, to support appropriate disease management 6) Improve indoor air quality Invitation to sign the EFA Call to Action: http://www.efacallaction.net/sign.aspx Antje-Henriette Fink-Wagner, 2012
  • 38. Patient Associations Patient Association Global Allergy and Asthma Patient Platform – 24 member organizations on all Continents – Sport Games for children with asthma to promote adherence to sport for asthmatics (see first talk of this session) Antje-Henriette Fink-Wagner, 2012 38
  • 39. Conclusion Adherence / Concordance will improve as the sum of individual advocacy initiatives by all allied healthcare professionals and the patients themselves. Antje-Henriette Fink-Wagner, 2012 39
  • 40. COMPLY – OR DIE Thank You! Antje-Henriette Fink-Wagner, 2012 40